| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.2 | 2e-05 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.19 | 0.0006 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0008 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |